PACIRA BIOSCIENCES, INC. (PCRX) Free cash flow 2016–2025
PACIRA BIOSCIENCES, INC. (PCRX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$136.7MFY2025 · since FY2016: $8.7M → $136.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $136.7M | -23.5% |
| FY2024 | $178.8M | +28.1% |
| FY2023 | $139.5M | +21.1% |
| FY2022 | $115.2M | +44.3% |
| FY2021 | $79.9M | +103.5% |
| FY2020 | $39.2M | -35.0% |
| FY2019 | $60.4M | +75.7% |
| FY2018 | $34.4M | +2419.8% |
| FY2017 | -$1.5M | -116.9% |
| FY2016 | $8.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PCRX financial trends
PCRX RevenuePCRX Net incomePCRX Net marginPCRX Gross profitPCRX Gross marginPCRX Operating incomePCRX Operating marginPCRX Operating cash flowPCRX Capital expendituresPCRX Return on equityPCRX Stock buybacksPCRX Dividends paidPCRX Total assetsPCRX Total liabilitiesPCRX Shareholders’ equityPCRX overview →